Did pharma overshoot digital sales rep calls? Study charts decline in effectiveness

A year after the pandemic forced pharma reps to switch from in-person to digital sales calls, most visits are still virtual—and the industry is seeing mixed results.

The good news is that in-person pharma sales calls are now in demand by physicians. Last month, 44% of healthcare professionals said face-to-face sales visits are their preferred option for pharma promotions, according to the latest study from healthcare consultancy ZoomRx.

Even more encouraging for reps is that the face-to-face visits are garnering positive prescription intent—17% higher than before the pandemic began.